Emend and Pregabalin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Emend (aprepitant) and Pregabalin (pregabalin). Common drug interactions include sleep disorder among females and bronchitis among males.
The phase IV clinical study analyzes what interactions people have when they take Emend and Pregabalin. It is created by eHealthMe based on reports of 198 people who take the same drugs from the FDA, and is updated regularly.
What is Emend?
Emend has active ingredients of aprepitant. It is often used in nausea. eHealthMe is studying from 13,741 Emend users. Check the latest studies of Emend.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.
198 people who take Emend and Pregabalin together, and have interactions are studied.
What are the common drug interactions of Emend and Pregabalin, by gender? *
What are the common drug interactions of Emend and Pregabalin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Emend and Pregabalin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Emend (13,741 reports)
- Pregabalin (74,069 reports)
Browse all drug interactions of Emend and Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Emend:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emend and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pregabalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on aprepitant and pregabalin (the active ingredients of Emend and Pregabalin, respectively), and Emend and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cardizem vs. Amiloride Hydrochloride, side effect and effectiveness comparison - a second ago
- Could Reclast cause Accident? - a second ago
- Catapres-Tts-1 vs. Inderal, side effect and effectiveness comparison - 4 seconds ago
- Drug interactions of Mesalamine and Zejula - 10 seconds ago
- Loratadine And Pseudoephedrine Sulfate vs. Ketotifen Fumarate, side effect and effectiveness comparison - 13 seconds ago
- Could Linzess cause Tooth Abscess? - 13 seconds ago
- Lozol vs. Atacand, side effect and effectiveness comparison - 13 seconds ago
- Drug interactions of Amlodipine and Niaspan - 18 seconds ago
- Drug interactions of Levocetirizine Dihydrochloride and Ofev - 20 seconds ago
- Drug interactions of Amlodipine Besylate and Olive - 20 seconds ago